Extracellular matrix biomarker, fibulin-1 and its association with soluble uPAR in a bi-ethnic South African population: the SAfrEIC study.

Christine S du Plooy, Ruan Kruger, Hugo W Huisman, Lars M Rasmussen, Jesper Eugen-Olsen, Aletta E Schutte

Journal: Heart, lung & circulation 2015;24(3):298-305

PMID: 25456503

Abstract

BACKGROUND

Fibulin-1 and soluble urokinase-type plasminogen activator receptor (suPAR) emerged as mediators in the development of sclerotic disease. SuPAR along with C-reactive protein (CRP) and albumin delineate inflammatory processes associated with extracellular matrix turnover in atherosclerosis. We explored the independent relationship of fibulin-1 with these inflammatory markers in a bi-ethnic South African population.

METHODS

This study included 290 Africans (men: n=130 and women: n=160) and 343 sex- and age-matched Caucasians (men: n=160 and women: n=183). Serum fibulin-1, suPAR, CRP and albumin levels were measured along with conventional cardiovascular and metabolic variables.

RESULTS

In both single and age-adjusted regression analyses, fibulin-1 correlated with both suPAR and albumin in African men and with suPAR in Caucasian men. These findings were absent in women. In multivariate regression analysis, these associations were confirmed in African men (R(2)=0.22; β=0.329; p<0.001) and Caucasian men (R(2)=0.14; β=0.234; p=0.008). Fibulin-1 independently associated positively with suPAR in all men, but inversely with albumin in African men only.

CONCLUSIONS

These results are indicating the presence of potential subclinical inflammation (suPAR) within the extracellular matrix of endothelial tissue, contributing to the potential onset of cardiac fibrosis or vascular sclerosis among these South African men with lower albumin levels.

Copyright © 2014 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Address: Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.; Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa. Electronic address: [email protected].; Centre for Individualized Medicine (CIMA); Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Denmark.; Clinical Research Centre 136, Copenhagen University, Hvidovre Hospital, Hvidovre, Denmark.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.